These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 387810)

  • 1. Serotyping of Serratia marcescens: current status of seven recently described flagellar (H) antigens.
    Traub WH; Fukushima PI
    J Clin Microbiol; 1979 Jul; 10(1):56-63. PubMed ID: 387810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotyping of Serratia marcescens: evaluation of Le Minor's H-immobilization test and description of three new flagellar H antigens.
    Traub WH; Kleber I
    J Clin Microbiol; 1977 Feb; 5(2):115-21. PubMed ID: 321468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotyping of Serratia marcescens: simplified tube O-agglutination test and comparison with other serological procedures.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):474-93. PubMed ID: 396741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotyping of Serratia liquefaciens: H-antigens.
    Traub WH
    Zentralbl Bakteriol; 1991 Jun; 275(2):211-5. PubMed ID: 1718304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotyping of Serratia marcescens: confirmation of five recently described new O-antigens and characterization of an additional O-antigen.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):307-11. PubMed ID: 7029967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative biotyping, bacteriocin typing, and serogrouping (O-antigens) of Serratia liquefaciens.
    Traub WH
    Zentralbl Bakteriol; 1991 Jun; 275(2):200-10. PubMed ID: 1718303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards serodiagnosis of Serratia marcescens infections: examination of sera from noninfected patients and from experimentally infected rabbits for anti-H and anti-O antibodies; S. marcescens O-antigen cross-reactions with those of other enterobacteriaceae.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):490-6. PubMed ID: 7036590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase variation in the genus Serratia.
    Young VM; Moody MR; Morris MJ
    J Med Microbiol; 1980 May; 13(2):341-3. PubMed ID: 6991701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antigenic study of Serratia marcescens isolated in France. I.--Antigens: individualization of six new H factors (author's transl)].
    Le Minor S; Pigache F
    Ann Microbiol (Paris); 1977; 128(2):207-14. PubMed ID: 73361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epidemiological study of Serratia marcescens infections by bacteriocin typing.
    Nasu M; Goto J; Goto I
    Microbiol Immunol; 1982; 26(9):795-801. PubMed ID: 6759881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of clinical isolates of Serratia marcescens by bacteriocin typing: a comparison of bacteriocin types between two distant university hospitals].
    Nasu M; Goto J; Goto Y; Tashiro T; Itoga T; Yamaguchi K
    Kansenshogaku Zasshi; 1984 Apr; 58(4):312-7. PubMed ID: 6434655
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on group A (phage tail) bacteriocins of Serratia marcescens. V. Serological characterization of subgroup I and II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):521-7. PubMed ID: 779357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological studies of Serratia marcescens infections by bacteriocin (marcescin) typing.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):45-52. PubMed ID: 7015561
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotyping of Serratia marcescens using passive haemagglutination.
    Guinée PA; Jansen WH; Maas HM
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):105-19. PubMed ID: 2442923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals.
    Pitt TL; Erdman YJ; Bucher C
    J Hyg (Lond); 1980 Apr; 84(2):269-83. PubMed ID: 6987298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.